Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Van Diest

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pathology|June 16, 2001
New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridizationM Hermsen, M A Guervós, G Meijer, et al.
The British Journal of Dermatology|May 1, 1977
Preponderance of lysosomal bodies in cultured fibroblasts from patients with recessive epidermolysis bullosa dystrophica. An electron microscopic studyM W Kanan, M J Francis, B Sykes, et al.
Journal of Clinical Pathology|October 1, 1993
Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomasL C Wijnaendts, J C van der Linden, P van Diest, et al.
Oncogene|November 8, 2011
Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-αF Vesuna, A Lisok, B Kimble, et al.
Oncogene|February 12, 2008
Oncogenic role of DDX3 in breast cancer biogenesisM Botlagunta, F Vesuna, Y Mironchik, et al.
The Journal of Gene Medicine|September 11, 2002
Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcomaM A Witlox, V W Van Beusechem, J Grill, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2006
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)J A Green, E M J J Berns, C Coens, et al.
Pathology, Research and Practice|September 1, 1996
Standardized mitotic counts in breast cancer. Evaluation of the methodY U Collan, T Kuopio, J P Baak, et al.
Breast Cancer Research and Treatment|November 15, 2014
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyD Balmativola, C Marchiò, M Maule, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Pathology|June 16, 2001
New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridizationM Hermsen, M A Guervós, G Meijer, et al.
The British Journal of Dermatology|May 1, 1977
Preponderance of lysosomal bodies in cultured fibroblasts from patients with recessive epidermolysis bullosa dystrophica. An electron microscopic studyM W Kanan, M J Francis, B Sykes, et al.
Journal of Clinical Pathology|October 1, 1993
Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomasL C Wijnaendts, J C van der Linden, P van Diest, et al.
Oncogene|November 8, 2011
Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-αF Vesuna, A Lisok, B Kimble, et al.
Oncogene|February 12, 2008
Oncogenic role of DDX3 in breast cancer biogenesisM Botlagunta, F Vesuna, Y Mironchik, et al.
The Journal of Gene Medicine|September 11, 2002
Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcomaM A Witlox, V W Van Beusechem, J Grill, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2006
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)J A Green, E M J J Berns, C Coens, et al.
Pathology, Research and Practice|September 1, 1996
Standardized mitotic counts in breast cancer. Evaluation of the methodY U Collan, T Kuopio, J P Baak, et al.
Breast Cancer Research and Treatment|November 15, 2014
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyD Balmativola, C Marchiò, M Maule, et al.
Pageof 2